Medline (MDLN) Inventory (2024 - 2026)

Medline (MDLN) has 3 years of Inventory data on file, last reported at $4.8 billion in Q1 2026.

• On a quarterly basis, Inventory changed N/A year-over-year to $4.8 billion in Q1 2026; TTM through Mar 2026 was $4.8 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $4.8 billion, up 7.02% from the prior year.
• Inventory for Q1 2026 stood at $4.8 billion, up from $4.8 billion in the prior quarter.
• Over the last five years, Inventory for MDLN reached as high as $4.8 billion in Q1 2026 and fell as low as $4.5 billion in Q4 2024.
• Historically, Inventory has averaged $4.7 billion across 3 years, with a median of $4.8 billion in 2025.
• On a YoY basis, Inventory climbed as much as 7.02% in 2025 and fell as far as 7.02% in 2025.
• Year by year, Inventory stood at $4.5 billion in 2024, then climbed by 7.02% to $4.8 billion in 2025, then increased by 0.8% to $4.8 billion in 2026.
• Per Business Quant data, the three most recent Inventory figures were $4.8 billion in Q1 2026, $4.8 billion in Q4 2025, and $4.5 billion in Q4 2024.